General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Overcome(MODEST), Voxmedia(MODEST), Radcliffe(MODEST), WebMD(MODEST), CERC(MODEST), IQVIA(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Applied Therapeutics(SIGNIFICANT), STEL(SIGNIFICANT), STEL(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Daiichi Sankyo(NONE) OTHER FINANCIAL BENEFIT: ControlRad(MODEST), Elixir(SIGNIFICANT), WebMD(SIGNIFICANT)

View Full Disclosure